Reuters -- Teva Pharmaceutical Industries has exercised an option to raise its stake in Andromeda Biotech, which is developing a treatment for juvenile Type I diabetes, Clal Biotechnology Industries said on Monday.
Reuters -- Teva Pharmaceutical Industries has exercised an option to raise its stake in Andromeda Biotech, which is developing a treatment for juvenile Type I diabetes, Clal Biotechnology Industries said on Monday.
